DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/tlw7ks/global_insomnia) has announced the addition of the "Global Insomnia Pipeline Capsule - 2013" report to their offering.
Fore Pharma's latest report Global Insomnia Pipeline Capsule - 2013' provides up-to-date information on key Research and Development (R&D) activities in the global insomnia market. It covers active insomnia pipeline molecules in clinical trials, preclinical research, and drug discovery.
This report helps executives track competitor pipeline molecules. The pipeline data presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
The scope of the report includes information on insomnia pipeline molecules by clinical trial stages, company, mechanism of action, and country (The US, Germany, France, Italy, Spain, UK, Japan, and Rest of the World). Insomnia pipeline molecules licensing activities are also covered in this report.
Key Topics Covered
1. Insomnia - Disease Overview
2. Insomnia Pipeline Overview
3. Insomnia Pipeline by Geography
4. Insomnia Phase 3 Clinical Trial Pipeline Insights
5. Insomnia Phase 2 Clinical Trial Pipeline Insights
6. Insomnia Phase 1 Clinical Trial Pipeline Insights
7. Insomnia Preclinical Research Pipeline Insights
8. Insomnia Drug Discovery Pipeline Insights
9. Insomnia Market - Licensing Activities
10. Appendix
11. Research Methodology
For more information visit http://www.researchandmarkets.com/research/tlw7ks/global_insomnia
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
